Constellation

Cellular Origins Acquires ACTIA Platform IP Revolutionizing Cell Therapy Manufacturing

1. 📣 Exciting news! Cellular Origins acquires ACTIA Platform IP for cell therapy manufacturing, revolutionizing the industry! 🧪 2. 🚀 Accelerate your cell therapy manufacturing with Cellular Origins' robotic solution, Constellation™. The future is here! 3. 💡 Introducing Constellation™ - the scalable system that integrates automation robotics and aseptic fluid-handling technologies. 4. 👩‍🔬 Breakthrough acquisition! Cellular Origins solves the challenge of large-scale cell therapy production with ACTIA Platform.